Colossal, the company behind efforts to de-extinct the woolly mammoth and other long gone species announced Tuesday its ...

Colossal’s purchase of ViaGen, known for cloning pets of celebrities, bolsters the biotech firm’s tools for de-extinction and ...

Viagen Pets and Equine is a biotechnology company that will produce genetic twins of customers' pets and livestock. But its conservation efforts are what attracted Colossal.

Colossal Biosciences expands its de-extinction mission by acquiring Viagen, the world leader in animal cloning and species ...

The $10 billion de-extinction firm, led by Ben Lamm, has acquired Austin’s Viagen Pets and Equine to advance its species preservation mission.

Colossal Biosciences has expanded its efforts to save animals currently on the brink with its acquisition of the cloning ...